GlassScriptPhysician profile
Kevin Mangum
NPI 1609140847
$2,308.13
in general payments reported to CMS, 2019-2025
35 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what 90% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $386 · 2023: $186 · 2024: $528 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.71 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $286.23 | 2022-2025 | |
| Phathom Pharmaceuticals, INC. | $276.29 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $249.92 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $238.44 | 2024-2025 | |
| Amgen INC. | $229.04 | 2025 | Repatha, Otezla |
| Lilly USA, LLC | $163.77 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $90.92 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Shield Therapeutics INC | $72.70 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $61.22 | 2022 | |
| Medtronic, INC. | $58.15 | 2023-2024 | Intellis Adaptivestim |
| W. L. Gore & Associates, INC. | $50.00 | 2024 | Gore-Tex Vascular Graft |
| Nevro Corp. | $49.41 | 2021-2023 | Senza |
| Sanofi-Aventis U.S. LLC | $42.68 | 2022-2023 | |
| Lucid Diagnostics INC. | $40.43 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.07 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $35.12 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $32.56 | 2022 | |
| Inspire Medical Systems, INC. | $25.22 | 2025 | Inspire |
| Rgh Enterprises LLC | $23.00 | 2025 | |
| Abbott Laboratories | $21.93 | 2025 | Freestyle Libre 3 |
| Ultragenyx Pharmaceutical INC. | $20.32 | 2022 | |
| Merck Sharp & Dohme LLC | $18.83 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.48 | 2021 | |
| Boston Scientific Corporation | $17.83 | 2024 | |
| Celgene Corporation | $16.96 | 2023 | Zeposia |
| Idorsia Pharmaceuticals US INC | $15.62 | 2024 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $15.38 | 2021 | |
| Glaxosmithkline, LLC. | $15.30 | 2021 | |
| Cranial Technologies, INC | $14.67 | 2022 | |
| Currax Pharmaceuticals LLC | $13.95 | 2022 | |
| Amarin Pharma, INC. | $13.14 | 2021 | |
| Dynavax Technologies Corporation | $12.27 | 2022 | |
| Axonics, INC. | $12.09 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.84 | 2022 | |
| Organon LLC | $6.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mangum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.